Sign In
Buy OBSV
$0.102
+0 (+0%)
At Close: Jun 21, 2023
Obseva SA (NASDAQ:OBSV) Given Average Recommendation of "Buy" by Analysts
05:58am, Tuesday, 21'st Apr 2020
Shares of Obseva SA (NASDAQ:OBSV) have been assigned an average rating of “Buy” from the seven research firms that are presently covering the stock, MarketBeat.com reports. One investment analyst
Edited Transcript of OBSV.O earnings conference call or presentation 7-Aug-19 12:00pm GMT
08:10pm, Monday, 20'th Apr 2020
Q2 2019 Obseva SA Earnings Call
Edited Transcript of OBSV.O earnings conference call or presentation 7-Aug-19 12:00pm GMT
01:55pm, Monday, 20'th Apr 2020
Q2 2019 Obseva SA Earnings Call
ObsEva to Increase Issued Share Capital by Creating Additional Treasury Shares
05:00am, Tuesday, 14'th Apr 2020
Tuesday 14, 2020 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a Swiss clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious condition
Renaissance Technologies LLC Boosts Stake in Obseva SA (NASDAQ:OBSV)
08:20am, Monday, 13'th Apr 2020
Renaissance Technologies LLC lifted its holdings in Obseva SA (NASDAQ:OBSV) by 154.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchan
Why ObsEva SA’s (NASDAQ:OBSV) CEO Pay Matters To You
04:42pm, Wednesday, 08'th Apr 2020
In 2012 Ernest Loumaye was appointed CEO of ObsEva SA (NASDAQ:OBSV). First, this article will compare CEO compensation...
Obseva (NASDAQ:OBSV) Trading Up 7.7%
10:16am, Tuesday, 07'th Apr 2020
Obseva SA (NASDAQ:OBSV)’s share price was up 7.7% during trading on Monday . The company traded as high as $2.36 and last traded at $2.25, approximately 326,787 shares changed hands during trading.
ObsEva SA Announces New Interim Chief Financial Officer
05:00am, Monday, 06'th Apr 2020
April 6, 2020 – ObsEva SA (OBSV), a clinical-stage biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health today announced the nomination of
Analysts Offer Insights on Healthcare Companies: ObsEva SA (OBSV), AC Immune SA (ACIU) and Co-Diagnostics (CODX)
11:15am, Wednesday, 01'st Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on ObsEva SA (OBSV), AC Immune SA (ACIU) and Co-Diagnostics
Analysts Offer Insights on Healthcare Companies: ObsEva SA (NASDAQ: OBSV), AC Immune SA (NASDAQ: ACIU) and Co-Diagnostics (NASDAQ: CODX)
11:15am, Wednesday, 01'st Apr 2020
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on ObsEva SA
Obseva (NASDAQ:OBSV) Upgraded by Zacks Investment Research to Buy
09:00am, Saturday, 28'th Mar 2020
Obseva (NASDAQ:OBSV) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued on Saturday, Zacks.com reports. The brokerage presently has a
ObsEva SA: New Date Announcement for AGM
06:00am, Friday, 27'th Mar 2020
Geneva, Switzerland and Boston, MA – March 27, 2020 – ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company developing and commercializing novel therapies to.
Obseva SA (NASDAQ:OBSV) Receives Average Rating of "Hold" from Analysts
05:22am, Friday, 27'th Mar 2020
Obseva SA (NASDAQ:OBSV) has earned an average recommendation of “Hold” from the seven research firms that are currently covering the stock, MarketBeat.com reports. Two research analysts have rated
Edited Transcript of OBSV.O earnings conference call or presentation 5-Mar-20 1:00pm GMT
11:24pm, Thursday, 26'th Mar 2020
Q4 2019 Obseva SA Earnings Call
Obseva (NASDAQ:OBSV) Shares Up 5.1%
08:34am, Thursday, 26'th Mar 2020
Obseva SA (NASDAQ:OBSV) shot up 5.1% during mid-day trading on Tuesday . The stock traded as high as $2.11 and last traded at $2.07, 276,091 shares changed hands during trading. A decline of 60% from
